a new weekly formulation of established GLP-1 diabetes drug with the added benefit of glucose reduction, better weight loss results and a new injection pen. AstraZeneca announced that the EC green ...

Injection pens are becoming increasingly popular due to their ease of use, portability, and ability to enhance patient adherence to prescribed treatments. They are widely used for managing chronic ...